Why Skin Health Is Still Mostly Measured at the Surface

15 Apr

For decades, skin health has been defined by what we can see. Clinical assessment has largely relied on visual inspection:

what appears on the surface,
what can be visually enhanced or interpreted through imaging
what changes over time,
and what a patient reports noticing.

It’s a model that has guided dermatology, aesthetics, and research for years. But most meaningful biological activity doesn’t happen at the surface. Even with advances in imaging, most technologies still derive insight from what is visible—rather than directly measuring the biological signals beneath the surface.

It happens beneath it.

That gap — between what’s visible and what’s actually happening beneath the surface — is where uncertainty persists—and where decisions are made without full biological insight.

The Current Standard: What’s Broken

Today, most skin health assessments whether for skin cancer detection or evaluating the effectiveness of a skin treatment or intervention rely on a combination of:

Visual assessment and investigator grading
Imaging-based evaluation and interpretation
Patient-reported outcomes

These tools are valuable, but they share a fundamental limitation: they rely heavily on interpretation rather than direct, quantitative measurement and do not capture what is happening below the surface.

Two clinicians may assess the same area and reach different conclusions, particularly when evaluation is based on visual interpretation alone. Subtle changes can be difficult to quantify. And without consistent objective measurements, tracking progression over time becomes inherently imprecise.

The result is a system shaped by:

Subjectivity — dependent on clinician experience and perspective
Variability — differences across providers, settings, and time
Limited longitudinal insight — difficulty measuring change in a meaningful, standardized way

In many cases, we are still making clinical decisions based on what is visible and not what is measurable.

Why This Matters: Real-World Consequences

These limitations are not theoretical. They directly impact outcomes related to skin health.

Early-stage skin conditions can be subtle, evolving beneath the surface before becoming visible. When detection relies primarily on visual cues, there is an inherent risk of delay.

Across providers, variability in interpretation can lead to inconsistent assessments affecting diagnosis, treatment decisions, and patient confidence.

And without an objective baseline, it becomes difficult to answer fundamental questions:

Is a condition improving or progressing?
Is a treatment working?
How does one patient’s response compare to another’s?

This gap shows up across:

Skin cancer detection — where earlier identification can significantly impact outcomes
Aesthetic treatments — where results are often evaluated subjectively or through surface-level changes
Clinical trials — where variability in measurement directly impact data quality, end point reliability and comparability

In each case, the challenge is the same: we are trying to assess a biological system without fully measuring it.

The Blind Spot: Subsurface Biology

Beneath the skin’s surface lies a complex system of biological signals, and many of which directly influence health, risk, and response to treatment.

Key among these are chromophores such as:

Collagen — reflecting structural integrity and skin tissue architecture
Melanin — indicating pigmentation patterns and UV response
Hemoglobin — providing insight into vascular activity and inflammation

These signals have always existed. They are fundamental to how skin behaves, ages, and responds. What’s been missing is the ability to measure them in real time; consistently, non-invasively, and in a clinically usable way.

As a result, much of skin health has remained a visual approximation of a deeper biological reality.

A Shift in Perspective

What’s changing is not just technology, but how we define skin health itself.

We are moving from:

Surface → Subsurface
Subjective → Objective
Snapshot → Longitudinal

This shift reframes skin health as something that can be measured, tracked, and compared over time and not just observed in isolated moments.

It introduces the possibility to establish objective baselines, detect subtle changes earlier, and evaluating outcomes with greater precision.

In doing so, it establishes a new standard for how skin health is understood, where decisions are grounded in measurable data, not interpretation alone.

What This Enables

When skin health becomes measurable, entirely new capabilities emerge.

Earlier detection — identifying biological change before it becomes visible at the surface
Greater Consistency— reducing variability in assessment and decision-making
True Longitudinal tracking — enabling consistent measurement of change and response over time

It also creates a foundation for more reliable clinical research, more personalized patient care, and more confident, data- driven decision-making.

Rather than relying on isolated observations, clinicians and researchers can begin to work with continuous, objective insight.